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Introduction
Extramammary Paget’s disease (EMPD) accounts for
6.5% of all cases of Paget’s disease1 and is a rare cuta-
neous carcinoma of epidermal origin and glandular
differentiation. It usually occurs in sites containing
apocrine glands and can be associated with an under-
lying adnexal carcinoma or internal malignancy.
There have been several reports of EMPD asso-
ciated with carcinoma of the bladder,2 prostate,2,3
kidney,2,4 and colon.3 The association of hepatocellular
carcinoma (HCC) with EMPD appears to be exceed-
ingly rare; to our knowledge, it has been reported only
once in the English-language literature.5
Herein, we report an unusual case of EMPD asso-
ciated with HCC and review the literature on this rare
disease entity.
Case Report
A 60-year-old man with scrotal Paget’s disease was
admitted because of neck and bilateral shoulder pain
for 1 month.
Thirty-one months before admission, the patient had
found an erythematous plaque on his right scrotum.
Despite conventional treatment, the lesion extended
to the whole scrotum, penile phallus, right thigh, and
perineal and suprapubic regions over the course of 
the following year (Figure 1). Nineteen months before
admission, the patient underwent a wide excision of
the lesion and rotational flap repair. Histological exam-
ination of the resected specimen led to the diagnosis of
EMPD (Figure 2). Laboratory examination revealed
normal levels of aspartate aminotransferase (AST) and
alanine aminotransferase (ALT); the patient did not
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know whether he had had previous hepatitis infection.
He also received gastroscopy, colonofibroscopy and
intravenous pyelography plus post-voiding examina-
tions; the results were normal. He was then regularly
followed-up at the outpatient department.
On this current admission, physical examination
revealed no local tumor recurrence. Laboratory exam-
inations revealed serum AST level of 79.83 U/L,
serum ALT level of 62.72 U/L, and positive HBsAg.
Serum carcinoembryonic antigen level was normal, but
the α-fetoprotein level was 271.26 ng/mL. C-spine
radiography showed osteolytic change, especially at
C5–7 (Figure 3). Magnetic resonance imaging of the
spine disclosed multiple signal abnormality mass lesions
over the C-spine and T-spine vertebrae, and narrowing
of the spinal canal (Figure 4). Bony metastases were
established.
Abdominal computed tomography revealed an ill-
defined tumor mass about 5.0 × 5.7 cm in size in S6
of the liver (Figure 5). Sonoguided needle biopsy was
Figure 1. Erythematous plaques over the scrotum, penile phallus,
right thigh, and perineum and suprapubic regions. A tumor mass
over the right scrotum was also noted.
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Figure 2. Histological findings of extramammary Paget’s disease. (A) The epithelium was diffusely infiltrated by Paget cells, singly or in
clusters (hematoxylin & eosin, 400×). (B) The cells were large, with abundant pink-staining cytoplasm and vesicular nuclei with prominent
eosinophilic nucleoli (hematoxylin & eosin, 200×). (C) The cells stained positive for mucicarmine (100×). (D) The cells revealed strongly
positive reactions to epithelial membrane antigen (200×).
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performed and HCC was diagnosed (Figure 6). The
clinical condition of the patient deteriorated rapidly,
and he died 1 month later.
Discussion
Paget’s disease, usually occurring in sites containing
apocrine glands, is an intraepidermal adenocarcinoma
of the nipple and/or areola of the breast (mammary
Paget’s disease; MPD) or in extramammary body zones
such as the anogenital and perineal skin and the axilla
(EMPD).
EMPD primarily affects elderly people2 between
65 and 70 years of age; 90% of cases occur in people
older than 50 years.6,7 It is seen more frequently in
females than males, and occurs predominantly in the
vulva, followed by the perianal region.2 The scrotum
is an uncommon site for the presentation of EMPD,
and only small series or a few case reports have been
reported. The typical appearance of EMPD is a single
or multifocal erythematous and eczematoid plaque.
Pruritus is the most common symptom. It is often
mistaken for an inflammatory or infective condition,
and the diagnosis is often delayed by an average of 2–3
years after disease onset.3
Figure 3. Radiography shows osteolytic change in the C-spine
(arrows), in favor of metastatic lesions.
Figure 4. Magnetic resonance imaging shows multiple signal
abnormality mass lesions over the C-spine and T-spine, with low
signal intensity on T1-weighted imaging (arrows) and high signal
intensity on gradient echo imaging (arrowheads), causing narrow-
ing of the spinal canal and cord compression, especially at the
C7 and T1 vertebral level. Metastatic malignancy was indicated.
Figure 5. Abdominal computed tomography reveals an ill-defined
tumor mass (arrow) with peripheral irregular contrast enhance-
ment (arrowhead) in S6 of the liver. The differential diagnoses
included primary hepatic malignancy and metastasis.
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MPD, first described by James Paget in 1874,8 is,
as a rule, associated with underlying breast cancer.
EMPD, first described by Crocker in 1889,9 shares
many common clinicopathological features with MPD,
whereas association of EMPD with underlying malig-
nancies occurs much less frequently.
Because of the rarity of EMPD, most reports con-
sist of individual case studies or small series. In a retro-
spective analysis of 197 cases of EMPD reported in the
English literature from 1962 to 1982, Chanda2 found
that 46 (24%) cases had an underlying adnexal carci-
noma. The incidence of underlying adnexal carcinoma
has been reported to vary, and it depends on the
anatomic sites affected. Reported frequencies are from
14% to 20% in patients with vulvar EMPD,10,11 and
from 50% to 86% in perianal EMPD.12 The incidence
of underlying adnexal carcinoma in penoscrotal EMPD
is exceedingly rare, and only a few studies have been
reported. Lai et al3 reported that 7 (21.2%) of 33
patients had underlying adnexal carcinoma. No patient
had underlying adnexal carcinoma in Wada and Urabe’s
study,13 but some did in Yang et al’s report.4
The question of the relationship of EMPD to in-
ternal malignancy is difficult. There seems to be an
impression in the literature that EMPD is associated
with underlying internal malignancy and occurs con-
currently with or before the internal malignancy.
Therefore, there is a suggestion that EMPD may be a
cutaneous marker for internal malignancy.2,14,15 In
Chanda’s study,2 the location of the underlying inter-
nal malignancy appeared to be closely related to the
location of the EMPD, that is, a vulvar location was
associated with malignancy of the female genitouri-
nary system. A perianal location was associated with
adenocarcinoma of the digestive system, and a peno-
scrotal location with genitourinary malignancy.
In Chanda’s analysis,2 4 (22.2%) of 18 patients
with penoscrotal EMPD had internal malignancies 
(1 bladder carcinoma, 1 renal cell carcinoma, 2 prostate
carcinomas). Lai et al3 reported that 3 (9.1%) of 33
patients with penoscrotal EMPD had associated inter-
nal malignancy (1 rectosigmoid carcinoma, 2 prostate
carcinomas). Yang et al4 reported that 1 (2.8%) of 36
patients with penoscrotal EMPD had internal malig-
nancy (renal cell carcinoma). None of the 22 patients
with penoscrotal EMPD had an associated internal
malignancy in Chang et al’s study.16
However, in our case, the location of the under-
lying malignancy was not closely related to the genito-
urinary location of the penoscrotal EMPD. The same
findings were reported by Lai et al,3 in that 1 patient
with penoscrotal EMPD had an associated rectosig-
moid carcinoma, and Saitou et al5 reported that 1 pa-
tient with scrotal EMPD had an associated underlying
HCC. Therefore, it is suggested that in patients with
penoscrotal EMPD, not only the genitourinary sys-
tem but also the digestive system should be examined
for the possibility of associated internal malignancy.
Based on recent reports of penoscrotal EMPD,3,16–18
the prevalence of internal malignancy is 8.9% in Ori-
ental males.19 It is tempting to speculate that the inci-
dence of penoscrotal EMPD is high in Asians, but the
incidence of associated internal malignancy in Asians
seems to be lower than in Caucasians.3,16 The precise
pathogenesis of EMPD remains unknown, and the
mechanism of EMPD associated with underlying ma-
lignancies is also unclear; however, any molecular fac-
tors could be related. Our patient had HBV infection,
and the patient reported by Saitou et al5 had HCV
infection. It is possible that HBV or HCV influences
the DNA and leads to carcinogenesis of mucosa cells
as well as hepatocytes, resulting in the development of
EMPD and HCC; however, more studies are needed
to elucidate the mechanisms involved.5,20,21
Although we did not know the hepatitis status of
our patient before the diagnosis of HCC, based on the
fast tumor growth rate of HCC (with a doubling time
that ranges from 29 to 398 days, and an arithmetic
mean of 136 days),22 the time sequence of HCC after
EMPD is reasonable. This further confirms the litera-
ture findings that EMPD could occur before internal
malignancy and may be a cutaneous marker for inter-
nal malignancy.2,14,15
The usual treatment of EMPD is surgical. However,
due to the multicentricity and ill-defined disease mar-
gins, even extensive resections are complicated by a
high local recurrence rate.23–25 The level of invasion
Figure 6. The tumor cells of the hepatocellular carcinoma have
eosinophilic cytoplasm, distinct cell borders, and prominent
nuclei and nucleoli. A trabecular pattern of growth was also noted
(hematoxylin & eosin, 400×).
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and whether or not there are multiple lymph node me-
tastases are important prognostic factors in EMPD.26
Owing to invasive EMPD being frequently associated
with regional lymph node metastasis and having a
poor prognosis, intraoperative frozen section to reduce
the risk of incomplete resection and thus to reduce
the rate of recurrence is recommended.4,19
In conclusion, EMPD is an uncommon neoplasm
of apocrine gland-bearing skin. The diagnosis is fre-
quently delayed. EMPD has a tendency to be associ-
ated with underlying adnexal or internal malignancy.
In patients with nonspecific skin lesions that are unre-
sponsive to conventional treatment, EMPD should be
considered and skin biopsy performed. Long-term
follow-up is needed to watch for the appearance of
adnexal carcinoma or internal malignancy.
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